HansBiomed Corporation (042520) — Long-term Investment Intensity

Latest as of December 2019: 0.1%

HansBiomed Corporation (042520) has a Long-term Investment Intensity of 0.1% as of December 2019. Long-term investments of ₩200.00 Million represent 0.1% of total assets of ₩136.98 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check HansBiomed Corporation (042520) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

LT Investment Intensity

0.1%
LT Investments / Total Assets

Long-term Investments

₩200.00 Million
KRW

Total Assets

₩136.98 Billion
KRW

Country

Korea
KQ

HansBiomed Corporation Long-term Investment Intensity (2017–2019)

This chart shows how HansBiomed Corporation's Long-term Investment Intensity has evolved across 3 annual periods from 2017 to 2019. As of December 2019, the intensity stands at 0.1%, reflecting long-term investments of ₩200.00 Million against total assets of ₩136.98 Billion KRW. Explore 042520 cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.

Annual Long-term Investment Intensity for HansBiomed Corporation (2017–2019)

The table below presents the year-by-year Long-term Investment Intensity for HansBiomed Corporation from 2017 to 2019, covering 3 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see 042520 market cap.

Year LT Investment Intensity LT Investments (KRW) Total Assets Change (pp)
2019 0.1% ₩200.00 Million ₩134.09 Billion ▼ -1.8 pp
2018 1.9% ₩1.74 Billion ₩91.80 Billion ▲ +1.9 pp
2017 0.0% ₩10.00 Million ₩80.19 Billion
pp = percentage points